New Stocks News | It is rumored that Agna Biological Pharmaceuticals has selected a investment bank to secretly submit an application for a Hong Kong IPO, aiming to raise hundreds of millions of dollars.

According to the Wise Financial APP, it has been revealed by sources familiar with the matter that the Chinese biotechnology company Agenus Biopharmaceuticals Limited has selected an investment bank in Hong Kong for its initial public offering (IPO), with the IPO fundraising scale potentially reaching billions of dollars. The sources mentioned that Agenus Biopharmaceuticals is currently cooperating with Bank of America, CICC, Fosun Financial, and J.P. Morgan, and has secretly submitted an IPO application, but specific details such as scale and timing are still under discussion.